Elavil and Neurodermatitis - a phase IV clinical study of FDA data

Summary:

Neurodermatitis is reported as a side effect among people who take Elavil (amitriptyline hydrochloride), especially for people who are male, 50-59 old, also take Prilosec, and have Diabetes.

The phase IV clinical study analyzes which people have Neurodermatitis when taking Elavil. It is created by eHealthMe based on reports of 19,133 people who have side effects when taking Elavil from the FDA, and is updated regularly.

What is Elavil?

Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 20,724 Elavil users. Check the latest studies of Elavil.

What is Neurodermatitis?

Neurodermatitis (a skin disorder characterized by long lasting itching and scratching) is found to be associated with 322 drugs and 275 conditions by eHealthMe. Check the latest studies of Neurodermatitis.

On May, 03, 2026

19,133 people reported to have side effects when taking Elavil.
Among them, 12 people (0.06%) have Neurodermatitis.

Among these 12 people:

What is the gender of people who have Neurodermatitis when taking Elavil? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Neurodermatitis when taking Elavil? *

What are other drugs people take besides Elavil? *

What are other side effects people have besides Neurodermatitis? *

Tumor: 10 people, 83.33%
Neuropathy Peripheral (surface nerve damage): 9 people, 75.00%
Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 9 people, 75.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 9 people, 75.00%
Osteoporosis (bones weak and more likely to break): 9 people, 75.00%
Cataract (clouding of the lens inside the eye): 9 people, 75.00%
Pain: 9 people, 75.00%
Pneumonia: 9 people, 75.00%
Kidney Stones: 9 people, 75.00%
Renal Cyst (kidney cyst): 9 people, 75.00%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
Pain: 1 person, 8.33%
Impaired Gastric Emptying: 1 person, 8.33%
Herpes Zoster: 1 person, 8.33%
Diabetes: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Elavil and have Neurodermatitis?

- Check whether Neurodermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elavil:

Elavil (20,724 reports)

Neurodermatitis treatments and more:

Neurodermatitis (6,283 reports)

Browse all side effects of Elavil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neurodermatitis:

Neurodermatitis (322 drugs)

Browse all the conditions that are associated with Neurodermatitis:

Neurodermatitis (275 conditions)

Related publications that referenced our studies

Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride (the active ingredients of Elavil) and Elavil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.